Navigate the complexities of phase 1 clinical trials in Colombia with essential best practices.
Introduction Navigating the complexities of phase 1 clinical trials in Colombia is essential for sponsors seeking to thrive in a dynamic environment. With a regulatory framework shaped by INVIMA, the potential for expedited approval processes and enhanced patient recruitment strategies presents a unique opportunity for MedTech and Biopharma firms. Sponsors must prioritize compliance with local regulations while strategically optimizing their trial designs and operational efficiency. This article explores best practices that enable sponsors to streamline their clinical trial efforts, harnessing Colombia’s advantages for successful outcomes. Understand Colombia’s Regulatory Framework for Phase 1 Trials Understanding Colombia’s regulatory framework for phase 1 clinical trial Colombia is essential for sponsors aiming to successfully conduct first-in-human trials . The oversight framework is primarily directed by the National Food and Drug Surveillance Institute (INVIMA).…